Last reviewed · How we verify
NCT03654807
The Effect of Walking on Frailty
NA trial testing High Intensity Walking in Frailty in 156 participants. Completed in 31 May 2024.
31 January 2023
Quick facts
| Lead sponsor | Northwestern University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 156 |
| Start date | 26 November 2018 |
| Primary completion | 31 January 2023 |
| Estimated completion | 31 May 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- High Intensity Walking
- Casual Speed Walking
Conditions studied
- Frailty — all drugs for Frailty →
Sponsor
Northwestern University
Who can join
60 and older, any sex, with Frailty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to test the effect of walking intensity on both frailty category (i.e., frail, pre-frail, and nonfrail) and frailty score as a continuous outcome on the SHARE-FI (frailty instrument). As well as test the effect of walking intensity on mobility, physical function, balance, and total Physical Activity.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Factors That Influence Walking Intervention Adherence for Older Adults Living in Retirement Communities.
Davila VS, Conroy DE, Danilovich MK. · · 2022 · cited 4× · PMID 34384049 · DOI 10.1123/japa.2020-0279 -
Walking cadence as a measure of activity intensity and impact on functional capacity for prefrail and frail older adults.
Rubin DS, Hung A, Yamamoto E, Hedeker D, et al · · 2025 · cited 1× · PMID 40668771 · DOI 10.1371/journal.pone.0323759
Verify or expand the search:
- PubMed search for NCT03654807
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High Intensity Walking
Trials testing the same drug.
- NCT04241419 — A Pilot Study of High Intensity Walking in Older Adults in the Pre-operative Period · NA · terminated
- NCT03709251 — High Intensity Walking to Reduce Frailty · NA · terminated
Other recruiting trials for Frailty
Currently open trials in the same condition.
- NCT07481188 — Frailty and Nottingham Hip Fracture Score for Predicting 90-Day Mortality After Hip Fracture Surgery · recruiting
- NCT07519603 — Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program · NA · recruiting
- NCT07144527 — Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults · NA · recruiting
- NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home · NA · recruiting
- NCT07475767 — Ultrasound Indicators of Nutritional Status and Treatment Outcomes in Surgical Patients in the Intensive Care Unit · recruiting
Other Northwestern University trials
Trials by the same sponsor.
- NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
- NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
- NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
- NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
- NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03654807 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwestern University
- Last refreshed: 22 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03654807.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing